• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ABO血型不合所致溶血病新生儿与非溶血病新生儿的人口统计学特征和血液学参数比较。

Comparison of demographic characteristics and haematological parameters in newborns with and without haemolytic disease due to ABO incompatibility.

作者信息

Sahin Kamil, Aydın Tahir, Bilgin Demet Deniz, Büyükkayhan Derya, Elevli Murat

机构信息

Department of Pediatrics, University of Health Sciences, Haseki Training and Research Hospital, Sultangazi, İstanbul, Turkey.

出版信息

BMC Pediatr. 2025 Jul 30;25(1):582. doi: 10.1186/s12887-025-05935-8.

DOI:10.1186/s12887-025-05935-8
PMID:40739623
Abstract

BACKGROUND

ABO incompatibility is the most common blood group incompatibility in newborn babies, haemolytic disease develops in very few cases and is much milder than Rh incompatibility. In our study, we aimed to retrospectively examine the changes in platelet parameters, in addition to the expected decrease in the erythrocyte count, in immunized ABO incompatible patients, by comparing them with those in the control group.

METHODS

The demographic data and laboratory results of patients born in our hospital between November 1, 1997, and December 31, 2023, who had accessible information, were examined. The haemogram parameters of newborns with haemolytic disease who did not have ABO incompatibility those of newborns with ABO incompatibility and those of newborns with positive direct anti-globulin test results were compared using statistical methods.

RESULTS

A total of 5,198 out of 7,780 newborns were included in the study. A total of 2582 newborns for whom demographic and laboratory values ​​could not be obtained were excluded from the study. When the data of 5,158 newborns without incompatibility and 40 newborns with haemolytic disease due to ABO incompatibility were compared, the mean red blood cell (RBC), haematocrit, haemoglobin and mean platelet volume (MPV) values of newborns with haemolytic disease were found to be statistically significantly lower than those of newborns in the control group, whereas the platelet, mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC) and red cell distribution width (RDW) values were greater. Thrombocytopenia was not observed in any patient.

CONCLUSIONS

Haemolytic disease due to ABO incompatibility is a mild haemolytic disease that is thought to be caused by maternal antibody density or low antigen density on neonatal erythrocytes. We detected an increase in the platelet count and a decrease in the erythrocyte count values in in the haemolytic group. Prospective studies are needed on this subject that also examine erythropoietin and thrombopoietin values.

摘要

背景

ABO血型不合是新生儿中最常见的血型不合,极少数情况下会发生溶血病,且比Rh血型不合轻得多。在我们的研究中,我们旨在通过将免疫的ABO血型不合患者与对照组患者进行比较,回顾性地研究除红细胞计数预期下降外血小板参数的变化。

方法

对1997年11月1日至2023年12月31日在我院出生且有可获取信息的患者的人口统计学数据和实验室结果进行检查。使用统计方法比较了无ABO血型不合的溶血病新生儿、ABO血型不合的新生儿以及直接抗球蛋白试验结果为阳性的新生儿的血常规参数。

结果

7780名新生儿中共有5198名被纳入研究。共有2582名无法获得人口统计学和实验室值的新生儿被排除在研究之外。比较5158名无血型不合新生儿和40名因ABO血型不合导致溶血病的新生儿的数据时,发现溶血病新生儿的平均红细胞(RBC)、血细胞比容、血红蛋白和平均血小板体积(MPV)值在统计学上显著低于对照组新生儿,而血小板、平均红细胞体积(MCV)、平均红细胞血红蛋白(MCH)、平均红细胞血红蛋白浓度(MCHC)和红细胞分布宽度(RDW)值更高。未在任何患者中观察到血小板减少。

结论

ABO血型不合导致的溶血病是一种轻度溶血病,被认为是由母体抗体密度或新生儿红细胞上的低抗原密度引起的。我们在溶血病组中检测到血小板计数增加和红细胞计数值下降。需要对该主题进行前瞻性研究,同时也检查促红细胞生成素和血小板生成素的值。

相似文献

1
Comparison of demographic characteristics and haematological parameters in newborns with and without haemolytic disease due to ABO incompatibility.ABO血型不合所致溶血病新生儿与非溶血病新生儿的人口统计学特征和血液学参数比较。
BMC Pediatr. 2025 Jul 30;25(1):582. doi: 10.1186/s12887-025-05935-8.
2
[Analysis of ABO System Hemolytic Disease of the Newborn in 283 Cases at Yunnan Province].[云南省283例新生儿ABO血型系统溶血病分析]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2025 Jun;33(3):881-885. doi: 10.19746/j.cnki.issn.1009-2137.2025.03.039.
3
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
4
Transfusion thresholds for guiding red blood cell transfusion.输血阈值指导红细胞输血。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD002042. doi: 10.1002/14651858.CD002042.pub5.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Oral administration of Chinese herbal medicine during gestation period for preventing hemolytic disease of the newborn due to ABO incompatibility: A systematic review of randomized controlled trials.孕期口服中药预防ABO血型不合所致新生儿溶血病:随机对照试验的系统评价
PLoS One. 2017 Jul 18;12(7):e0180746. doi: 10.1371/journal.pone.0180746. eCollection 2017.
7
Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.对于接受强化化疗或放疗或两者联合治疗、有或没有造血干细胞支持的血液系统恶性肿瘤患者,采用限制性与宽松性红细胞输血策略的比较。
Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD011305. doi: 10.1002/14651858.CD011305.pub2.
8
Hyperbilirubinemia in neonates with blood group incompatibilities - A bane or a boon for the management.血型不相容新生儿的高胆红素血症——管理中的祸根还是福音?
Transfus Clin Biol. 2025 Feb;32(1):82-86. doi: 10.1016/j.tracli.2025.01.004. Epub 2025 Jan 13.
9
Treatment for women with postpartum iron deficiency anaemia.产后缺铁性贫血女性的治疗。
Cochrane Database Syst Rev. 2024 Dec 13;12(12):CD010861. doi: 10.1002/14651858.CD010861.pub3.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

1
Rates of phototherapy among ABO-incompatible newborns with a negative direct antiglobulin test.ABO 血型不合新生儿直接抗球蛋白试验阴性时的光疗比例。
J Perinatol. 2023 Nov;43(11):1357-1362. doi: 10.1038/s41372-023-01650-3. Epub 2023 Mar 23.
2
Hemolytic Disease of the Newborn: A Review of Current Trends and Prospects.新生儿溶血病:当前趋势与前景综述
Pediatric Health Med Ther. 2021 Oct 7;12:491-498. doi: 10.2147/PHMT.S327032. eCollection 2021.
3
Intravenous immunoglobulin G in the treatment of ABO hemolytic disease of the newborn during the early neonatal period at a tertiary academic hospital: a retrospective study.
三级学术医院新生儿早期 ABO 溶血病新生儿静脉注射免疫球蛋白 G 治疗:回顾性研究。
J Perinatol. 2021 Jun;41(6):1397-1402. doi: 10.1038/s41372-021-00963-5. Epub 2021 Feb 15.
4
Role of Cord Blood Carboxyhemoglobin in Detecting Significant Hyperbilirubinemia in Term Neonates with ABO Alloimmunization.脐血碳氧血红蛋白在检测ABO血型同种免疫足月儿严重高胆红素血症中的作用
Am J Perinatol. 2022 Sep;39(12):1321-1325. doi: 10.1055/s-0040-1722328. Epub 2021 Jan 4.
5
Erythropoietin is a major regulator of thrombopoiesis in thrombopoietin-dependent and -independent contexts.促红细胞生成素是血小板生成素依赖和非依赖情况下血小板生成的主要调节剂。
Exp Hematol. 2020 Aug;88:15-27. doi: 10.1016/j.exphem.2020.07.006. Epub 2020 Jul 25.
6
Severe ABO Hemolytic Disease of the Newborn Requiring Exchange Transfusion.新生儿严重ABO溶血病需换血治疗。
J Pediatr Hematol Oncol. 2019 Nov;41(8):632-634. doi: 10.1097/MPH.0000000000001248.
7
ACOG Practice Bulletin No. 192: Management of Alloimmunization During Pregnancy.美国妇产科医师学会临床实践公告第 192 号:孕期同种免疫的管理。
Obstet Gynecol. 2018 Mar;131(3):e82-e90. doi: 10.1097/AOG.0000000000002528.
8
Retrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 years.对某单一机构6年间因ABO血型不相容导致的新生儿溶血病进行回顾性分析。
Transfus Med. 2019 Jun;29(3):197-201. doi: 10.1111/tme.12512. Epub 2018 Jan 25.
9
Practice Bulletin No. 181: Prevention of Rh D Alloimmunization.第181号实践公告:预防Rh D血型同种免疫
Obstet Gynecol. 2017 Aug;130(2):e57-e70. doi: 10.1097/AOG.0000000000002232.
10
Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.胎儿及新生儿溶血病:母亲、胎儿及新生儿的管理
Hematology Am Soc Hematol Educ Program. 2015;2015:146-51. doi: 10.1182/asheducation-2015.1.146.